Sredni B, Matis L A, Lerner E A, Paul W E, Schwartz R H
J Exp Med. 1981 Mar 1;153(3):677-93. doi: 10.1084/jem.153.3.677.
The existence of T cells specific for soluble antigens in association with unique F(1) or recombinant major histocompatibility complex (MHC) gene products was first postulated from studies on the proliferative response of whole T cell populations to the antigen poly(Glu(55)Lys(36)Phe(9))(n) (GLphi). In this paper we use the newly developed technology of T lymphocyte cloning to establish unequivocally the existence of such cells specific for GLphi and to generalize their existence by showing that F(1)- specific cells can be isolated from T cell populations primed to poly(Glu(60)Ala(30)Tyr(10))(n) (GAT) where such clones represent only a minor subpopulation of cells. Gl.4b-primed B10.A(5R) and GAT-primed (B10.A x B10)F(1) lymph node T cells were cloned in soft agar, and the colonies that developed were picked and expanded in liquid culture. The GLphi-specific T cells were then recloned under conditions of high-plating efficiency to ensure that the final colonies originated from single cells. T cells from such rigorously cloned populations responded to stimulation with GILphi but only in the presence of nonimmune, irradiated spleen cells bearing (B10.A x B10)F(1) or the syngeneic B 10.A(5R) recombinant MHC haplotype. Spleen cells from either the B10 or B 10.A parental strains failed to support a proliferative response, even when added together. (B10 x B10.D2)F(1) and (B10 x B10.RIII)F(1) spleen cells also supported a proliferative response but (B10 x B10.Q)F(1) and (B10 X B10.S)F(1) spleen cells did not. These results suggested that the T cell clones were specific for GL[phi} in association with the beta(AE)(b)-alpha(E) (k,d,r,) Ia molecule and that recognition required both gene products to be expressed in the same antigen-presenting cells. Support for this interpretation was obtained from inhibition experiments using the monoclonal antibody Y-17 specific for a determinant on the beta(AE)(b)-alphaE Ia molecule. Y-17 completely inhibited the proliferative response of a GLphi-specific clone but had no effect on the response of either a PPD-specific or GAT-specific clone, both of which required the beta(A)-alpha(A) Ia molecule as their restriction element. No evidence could be found for the involvement of suppressor T cells in this inhibition. We therefore conclude that the phenomenon of F(1)-restricted recognition by proliferating T cells results from the presence of antigen- specific clones that must recognize unique F(1) or recombinant Ia molecules on the surface of antigen-presenting cells in addition to antigen in order to be stimulated.
针对可溶性抗原并与独特的F(1)或重组主要组织相容性复合体(MHC)基因产物相关的T细胞的存在,最初是从关于整个T细胞群体对抗原聚(Glu(55)Lys(36)Phe(9))(n)(GLphi)的增殖反应的研究中推测出来的。在本文中,我们使用新开发的T淋巴细胞克隆技术明确证实了此类针对GLphi的细胞的存在,并通过表明可以从用聚(Glu(60)Ala(30)Tyr(10))(n)(GAT)致敏的T细胞群体中分离出F(1)特异性细胞来推广它们的存在,其中此类克隆仅代表细胞的一小部分亚群。用Gl.4b致敏的B10.A(5R)和用GAT致敏的(B10.A×B10)F(1)淋巴结T细胞在软琼脂中克隆,培养出的集落被挑选出来并在液体培养中扩增。然后在高接种效率条件下对GLphi特异性T细胞进行再克隆,以确保最终的集落源自单细胞。来自此类严格克隆群体的T细胞对GILphi刺激有反应,但仅在存在携带(B10.A×B10)F(1)或同基因B10.A(5R)重组MHC单倍型的非免疫、经辐照的脾细胞时才有反应。来自B10或B10.A亲本菌株的脾细胞即使一起添加也无法支持增殖反应。(B10×B10.D2)F(1)和(B10×B10.RIII)F(1)脾细胞也支持增殖反应,但(B10×B10.Q)F(1)和(B10×B10.S)F(1)脾细胞则不支持。这些结果表明,T细胞克隆对与β(AE)(b)-α(E)(k,d,r,)Ia分子相关的GL[phi}具有特异性,并且识别需要这两种基因产物在同一抗原呈递细胞中表达。使用针对β(AE)(b)-αE Ia分子上一个决定簇的单克隆抗体Y-17进行的抑制实验支持了这一解释。Y-17完全抑制了GLphi特异性克隆的增殖反应,但对PPD特异性或GAT特异性克隆的反应均无影响,这两种克隆都需要β(A)-α(A) Ia分子作为其限制元件。未发现抑制性T细胞参与这种抑制作用的证据。因此,我们得出结论,增殖性T细胞的F(1)限制性识别现象是由于存在抗原特异性克隆,这些克隆除了识别抗原外,还必须识别抗原呈递细胞表面独特的F(1)或重组Ia分子才能被刺激。